A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Study Design:
Part 1.Randomized, double-blind, placebo-controlled, escalating single-dose design with
Healthy volunteers Part 2.Open , sequential, two-period, single dose study with type 1
diabetes Part 3.Open, sequential, two-period, single dose study with type 2 diabetes